Sorry this is not an answer to your questions. I would like to know how many patients out of the 6 in cohort 2 were moderate state of disease. Eventually in my mind a larger trial would be required with the moderate to severe ulcerative colitis patients. My guess is phase 2 with possibility of fast track designation at some point during the trial. I would also like to know if they are working on a combination of a pill along with the foam for ulcerative colitis to be tested in this phase2. I guess we'll know more after the BUP trial is completed. Results so far have been impressive compared to what's out there for first line treatment.
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links